[Activated protein C, coagulation, inflammation and treatment of severe sepsis].
van Zanten
A R
AR
Bakker
J
J
van den Berg
P C
PC
Girbes
A R
AR
van Leeuwen
S J
SJ
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D009426:Netherlands; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011486:Protein C / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy* / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins